Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Hydroxychloroquine sulfate

Hydroxychloroquine sulfate

pharmaceutical raw materials
Hydroxychloroquine sulfate structure

Hydroxychloroquine sulfate 

structure
  • CAS No:

    747-36-4

  • Formula:

    C18H26ClN3O.H2O4S

  • Chemical Name:

    Hydroxychloroquine sulfate

  • Synonyms:

    Ethanol,2-[[4-[(7-chloro-4-quinolinyl)amino]pentyl]ethylamino]-,sulfate (1:1);Ethanol,2-[[4-[(7-chloro-4-quinolyl)amino]pentyl]ethylamino]-,sulfate (1:1) (salt);Ethanol,2-[[4-[(7-chloro-4-quinolinyl)amino]pentyl]ethylamino]-,sulfate (1:1) (salt);7-Chloro-4-[4-N-ethyl-N-beta-hydroxyethylamino-1-methylbutylamino]quinoline sulfate;7-Chloro-4-[4-[ethyl(2-hydroxyethyl)amino]-1-methylbutylamino]-quinoline sulfate;Hydroxychloroquine sulfate;Plaquenil sulfate;Plaquenil;Quensyl;Ercoquin;NSC 4375;2-([4-[(7-Chloroquinolin-4-yl)amino]pentyl](ethyl)amino)ethan-1-ol sulfuric acid;2-((4-((7-Chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol sulfate;ZINC 01530654

  • Categories:

    Active Pharmaceutical Ingredients  >  Antiparasitic Drugs

Description

Hydroxychloroquine sulfate is a synthetic antimalarial drug which can also inhibit Toll-like receptor 7/9 (TLR7/9) signaling.


A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)

Hydroxychloroquine sulfate Basic Attributes

433.950

433.143829

212-019-3

758663|4375

DTXSID1047811

2933499090

Characteristics

131.37000

4.28400

Odorless Solid

240 °C

516.7ºC at 760 mmHg

266.3ºC

FREELY SOLUBLE

Store in a cool, dry place. Do not store in direct sunlight. Store in a tightly closed container.

178.4 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]

Safety Information

III

6.1

3276

3

R36/37/38

37/39-26

KK3342500

Xi: Irritant;

P280-P301 + P312 + P330-P305 + P351 + P338-P337 + P313

H302-H319

|Warning|H302 (94.23%): Harmful if swallowed [Warning Acute toxicity, oral]|P261, P264, P270, P271, P272, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P333+P313, P337+P313, P362, P363, P403+P233, P405, and P501|Aggregated GHS information provided by 52 companies from 11 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Drug Information

Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)|Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)|Drugs that are used to treat RHEUMATOID ARTHRITIS. (See all compounds classified as Antirheumatic Agents.)

Hydroxychlorochin

Hydroxychloroquine sulfate Use and Manufacturing

Uses

antimalarial, lupus suppressant An antimalarial; antirheumatic; lupus erythematosus suppressant

Human drugs -> Rare disease (orphan)|Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients

Drug Function and Efficacy

No specific information provided

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • SRINI PHARMACEUTICALS PRIVATE LTD

    United States United States
    Active
  • MSN LIFE SCIENCES PRIVATE LTD

    United States United States
    Active
  • ZHUHAI RUNDU PHARMACEUTICAL CO LTD

    United States United States
    Active

Recommended Suppliers of Hydroxychloroquine sulfate

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.